NCI vs AS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 25, 2026

NCI

44.4
AI Score
VS
AS Wins

AS

49.6
AI Score

Investment Advisor Scores

NCI

44score
Recommendation
HOLD

AS

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI AS Winner
Forward P/E 0 23.5849 Tie
PEG Ratio 1.13 0.7047 AS
Revenue Growth -50.8% 32.1% AS
Earnings Growth 34.0% 500.0% AS
Tradestie Score 44.4/100 49.6/100 AS
Profit Margin 0.2% 7.3% AS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NCI 1M: +13.3% · 3M: +46.2% AS 1M: -10.2% · 3M: -14.3%

Current Technical Phase

NCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 63

RSI (14): 62.8 · Price: $13.55

AS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.6%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $31.59

Fundamentals Snapshot

Metric NCI AS
Market Cap
Forward P/E 0.0 26.9
Trailing P/E 165.0 34.0
Revenue (TTM)
Revenue Growth -0.5% 0.3%
Gross Margin 0.4% 0.6%
Operating Margin 0.0% 0.1%
EPS 0.09 0.92
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.